Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial. - De Corso E; Canonica GW; Heffler E; Springer M; Grzegorzek T; Viana M; Horváth Z; Mullol J; Gevaert P; Michel J; Peters AT; Wagenmann M; et al. (The Lancet. Respiratory medicine, 2025)